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Abstract: Medicinal plants from the Egyptian Sinai Peninsula are widely used in traditional 
Bedouin medicine to treat a range of conditions including cancer, and as such are a promising 
resource for novel anti-cancer compounds. To achieve the scientific justification of traditional 
uses and/or to recommend the use of those plants as medicinal herbs for cancer 
chemoprevention, a group of eleven Sinai plants of different species that belong to three 
families (Asteraceae, Lamiaceae, and Euphorbiaceae) were biologically screened for cancer 
preventive activity using the chemoprevention marker enzyme NAD(P)H:quinone 
oxidoreductase 1 (NQO1). Among the fractions assayed, a solvent extract from Pulicaria 
incisa had potent NQO1 inducing activity. Further analysis of the mechanism of induction 
revealed the concentration dependent stabilization of the transcription factor NRF2 and a 
coordinate upregulation of the NRF2-dependent enzymes NQO1, hemeoxygenase 1 (HO-1) 
and glutathione S-transferase pi (GSTPi). These results establish P. incisa as a promising 
target for future phytochemical characterization for cancer preventive components. 
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Introduction 
Medicinal plants have been used for thousands of years as traditional treatments, and natural 
products (NPs) from these plants are still the basis for most modern medicines. Additionally, 
current studies of these traditional medicines continue to show that they are a rich source of 
biologically active compounds for the development of new pharmaceutical drug leads [1-3]. 
The awareness that one (or more) chemical entity within the plant material is responsible for 
a particular pharmacological action and can be isolated for the use as single agent began in 
the 19th century in the context of the emerging natural science-based medicine and pharmacy 
[4]. With the vast number of plant species present on the planet, since only ca. 1% have been 
characterized with respect to their phytochemical composition, there is a great potential for 
novel drug discovery. Interestingly in many under developed countries, traditional medicines 
directly extracted from plants is recognized as a rich source of drugs for primary healthcare 
needs [5]. 
The Sinai Peninsula is an epicentre of medicinal plants in the Arabian Desert. Such plant 
species are referred to as medicinal plants if they have been observed to have biological 
activity for humans and/or animals or are aromatic plants. The distribution, utilization in folk 
medicine and active constituents of medicinal plants in Sinai continue to attract the attention 
of many ecologists, taxonomists and phytochemists [6-11]. The arid environmental 
conditions combined with human activity have had a significant impact on the abundance, 
diversity and distribution of endemic medicinal plants [11-14]. South Sinai contains 472 plant 
species including 19 Egyptian endemic species, 115 of medicinal interest, and about 170 
species used in folk medicine [15]. Wild plant species in Sinai, Egypt were selected for this 
study based on the unique ecosystem giving rise to great plant diversity. Geographically, the 
region is characterized by large variations in landforms, water resources, aridity conditions 
and temperatures (i.e. cold winters, hot summers, low precipitation and high evaporation). As 
medicinal plants have been documented as a source of novel metabolites of pharmaceutical 
and agricultural importance, this study also aimed to give a deeper insight into the ‘enigma’ 
of endemic wild plants that are usually used by Bedouin of Sinai Peninsula. The findings will 
be instructive in identifying novel bioactive compounds from selected plants. 
While chemotherapeutic agents are initially cytotoxic to a variety of tumour cell lines and are 
effective in treating cancer, drug resistance often develops and is a major cause for 
discontinuation of a particular therapy [16]. Based on the classified stages of the 
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carcinogenesis process, the field of cancer chemoprevention is defined as the use of relatively 
non-toxic chemical agent (natural or synthetic) to inhibit, arrest or reverse the carcinogenesis 
at early stages [17-19]. The updated WHO traditional medicine strategy for the period 2014–
2023 devotes more attention than its predecessor to prioritizing health services and systems, 
including traditional and complementary medicine products, practices and practitioners. 
Several studies on the traditional use of Egyptian plants have documented various biological 
activities, including antibacterial and antifungal [20, 21], antiviral [22], cytotoxic [21, 23], 
and antioxidant [24].  
The activation of the transcription factor NF-E2 p45-related factor 2 (NRF2) and the resulting 
induction of its related gene products have been shown to play a key role in cancer 
chemoprevention. Many cytoprotective proteins such as NAD(P)H:quinone oxidoreductase 1 
(NQO1), hemoxygenase-1 (HO-1) and glutathione S transferases (GSTs) that catalyze the 
detoxification of procarcinogens and reduce of the endogenous levels of toxic reactive 
oxygen species are commonly transcribed via the NRF2 signalling [25]. NQO1 induction has 
been used as a marker for the chemopreventive potential of natural products and synthetic 
chemicals [26].  
As part of our continuing work to investigate and biologically evaluate the Egyptian wild and 
medicinal plants, the present study aimed to document the ethno-medicinal and/or 
recommended uses [27-33]. Here In the present study, eleven plants from different families 
were solvent extracted with either [MeOH:H2O (7:3) and CH2Cl2: MeOH (1:1)]. A total of 
twenty two extracts were tested using the NQO1 activity screening assay.  
 
Materials and Methods 
Plant material and extraction 
Eleven plants species were collected in June 2014, from South Sinai, Egypt and aerial parts 
were air-dried. Plants were identified and voucher specimenshave been deposited in the 
Herbarium of Saint Catherine protectorate, Egypt. The collection was performed under the 
permission of Saint Catherine protectorate for scientific purposes and officially permission 
was granted from the National Research Center. 
Two batches of aerial parts (100 g) of each plant were powdered and extracted with CH2Cl2-
MeOH (1:1) and MeOH-H2O (7:3) at room temperature. The filtrate solvents extract were 
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concentrated in vacuo using rotator evaporator to obtain a crude extract, resulting in twenty-
two crude extracts containing compounds with varying polarity. 
High performance liquid chromatography (HPLC) of the non polar extract from Pulicaria 
incisa (PI 1:1), which exhibited the most potent NQO1 inducing activity, was performed on 
an Agilent pump equipped with an Agilent-1200  HPLC instrument  using  variable 
wavelength UV detector at 220 and 254 nm using analytical column YMC-Pack ODS-A (250 
x 4.6 mm i.d.) (Fig. S1). 
 
Cell culture 
Murine hepatoma Hepa1c1c7 cells (obtained from ATCC®, USA) were grown in α-MEM 
supplemented with 10% (v/v) fetal bovine serum (heat-and charcoal-inactivated). Cells were 
routinely maintained in a humidified incubator at 37 °C, 5% CO2. 
Evaluation of NQO1 inducer activity  
A quantitative NQO1 microtiter plate assay was employed based on previously published 
protocols [26, 34]. For each experiment, cells (10,000 per well) were plated in 96-well plates. 
After 24 h, the cell culture medium was replaced with fresh medium containing plant extracts 
and the cells were incubated for an additional 48 h. Eight replicate wells of seven (0-50 
µg/ml) serial dilutions of each plant extract were tested. Plant extracts were prepared as stock 
solutions in DMSO, and then freshly diluted in the cell culture medium as 1:1000. The final 
concentration of DMSO in the medium was maintained at 0.1% (v/v). At the end of the 48 h 
exposure time, cells were lysed for 30 min at 25 °C in digitonin (0.8 g/L, pH 7.8). The 
specific activity of NQO1 was evaluated in cell lysates using menadione as a substrate. 
Protein concentrations were determined in each well by the BCA protein assay (Thermo 
Scientific, UK). Sulforaphane, a potent classical NQO1 inducer [35] was used as a positive 
control. 
Western Blotting for NRF2 and related targets 
For protein expression analysis of the potent NQO1 inducer extract, Hepa1c1c7 cells 
(overnight incubated monolayers of 3 × 10
5
 cells/well in 6-well plates) were treated with 
three concentrations of the plant extracts (3.125, 12.5 and 50 µg/ml) or vehicle (0.1% 
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DMSO). Sulforaphane (positive control) in 0.1% acetonitrile (ACN) was used as a known 
inducer of NRF2 and related target proteins. Cell lysates were prepared in RIPA buffer 
containing PMSF and protease inhibitors cocktail. Total proteins were measured using BCA 
assay. Samples were loaded into 10% Bis-Tris gel and run in 1x MOPS buffer at 150 Volts 
for 45 minutes. Resolved proteins were then transferred to nitrocellulose membranes at 60 
Volts for 2 h. Membranes were blocked in 5% non-fat milk in PBST for 1 h at 25 °C and then 
probed overnight (4°C) with primary antibodies against NRF2, NQO1, HO-1 and GST Pi (all 
are generous gifts from John Hayes, University of Dundee). Membranes were probed for β-
actin as loading control. After three washes in PBST (10 min each), membranes were probed 
with appropriate secondary antibodies for 1 h at 25 °C, washed three times in PBST and then 
developed using Enzyme Chemiluminescence. Protein bands were visualised on BioRad 
Chemidoc
®
Imager. 
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Results &Discussion 
Selected plants from Sinai were collected according to endemic and/or ethnobotanical uses in 
traditional medicines. The plants assayed included:Achillea fragrantissima (1, AF), Artemisia 
judica (2, AJ), Ballota undulata (3, BU), Euphorbia santa-catherine (4, ES), Phlomis aurea 
(5, PA), Pulicaria incisa (6, PI), Stachys aegyptiaca (7, SA), Pulicaria undulata (8, PU), 
Seriphidium herba-alba (9, SH), Teucrium polium (10, TP), Tanacetum sinaicum (11, TS). 
Photographs of these plants growing in their wild habitat are displayed in Fig.1. 
Hepa1c1c7 cells were incubated for 48 h with increasing concentrations (0-50 µg/ml) of each 
extract, and the activity of the NQO1 marker enzyme was quantified using the Prochaska 
assay. P. incisa (PI 1:1) resulted in the highest concentration-dependent induction of NQO1 
specific enzyme activity, as shown in Fig.2 and Table 1, where its CD value (the 
concentration needed to double the NQO1 activity by 2-fold relative to the solvent control) 
was 3.2 µg/ml. At 50 µg/ml, the highest concentration tested, the PI 1:1 extract led to a robust 
8-fold induction of the NQO1 specific enzyme activity. 
 
–Fig. 1– 
In contrast to the potent NQO1 inducer activity produced by the non-polar P. incisa extract 
(PI 1:1), the methanol:water (7:3) extract of this Pulicaria species (PI 70) caused a much 
weaker inducer activity (1.9 fold increase of the NQO1 activity over vehicle control) at the 
highest concentration of 50 µg/ml. Dose-dependent increases of NQO1 activity was found 
with extracts from P. undulata (PU 1:1), S. herba-alba (both SH 1:1 and SH 70), and T. 
sinaicum (both TS 1:1 and TS70 extracts) with CD values ranged between 5.0 and 10.0 µg/ml 
(Fig.2 and Table 1).Moderate NQO1 inducer activities (CD value between 12.0 and 16.0 
µg/ml) was recorded for extracts from A. fragrantissima (AF 1:1 and AF 70) and A. judica 
(AJ 1:1). Some of the tested extracts were weak NQO1 inducers, including B. undulata (BU 
1:1, CD=22 µg/ml), E. santa-catherine (ES 70, CD=31 µg/ml), T. polium (TP 1:1, CD=28) 
and S. aegyptiaca (SA 70, CD=50 µg/ml). The rest of tested plant extracts were devoid of 
pronounced NQO1 inducer activity so that they failed to reach a CD value even at 50 µg/ml, 
the highest concentration tested. 
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Because the NQO1 screening assay showed that the PI 1:1 extract has the most potent 
concentration-dependent induction of NQO1 specific enzyme activity (Fig.2 and Table 1), we 
focused our subsequent studies on this extract. The gene expression of NQO1 is mediated 
primarily through the activity of transcription factor NRF2. Under basal conditions, NRF2 is 
bound to its main negative regulator, Kelch-like ECH-associated protein 1 (KEAP1), which 
serves as a substrate adaptor protein for a Cullin-3/Rbx1 ubiquitin ligase and mediates the 
continuous ubiquitination and proteasomal degradation of NRF2. KEAP1 is also a cysteine-
based sensor for various endogenous and exogenous sulfhydryl-reactive small molecules 
(termed inducers), such as the isothiocyanate sulforaphane. Such compounds react and 
chemically modify the cysteine sensor(s) of Keap1 and disable its substrate adaptor activity, 
resulting in a rapid stabilization of NRF2. Therefore we next examined the protein levels of 
NRF2 after 4 h of exposure of Hepa1c1c7 cells to the PI 1:1 extract. As expected based on 
the NQO1 inducer activity, treatment with the PI 1:1 extract led to a concentration-dependent 
increase in the protein levels of NRF2 (Fig.3A).  
–Fig. 2, Table 1– 
Simultaneous induction of the expression of HO-1, another NRF2-target protein, was also 
evident at the 4 h time point. In agreement with the enzyme activity assay, the levels of 
NQO1 protein were also dose-dependently upregulated by exposure to the PI 1:1 extract for 
24 h (Fig. 3B). Finally, we examined levels of GST-Pi, another member of the NRF2-
regulated cytoprotective proteome after 24 h of treatment with PI 1:1. GST-Pi was found to 
be upregulated coordinately with HO-1 and NQO1. Notably, the increases in HO-1 and 
NQO1 were much more pronounced than the increase in GST-Pi (Fig.3C), further supporting 
the use of NQO1 as a sensitive marker for NRF2 activation. 
 
–Fig. 3– 
 
Our study has uncovered the value of the P. incisa non-polar extract (PI 1:1) as an activator 
of the NRF2-dependent enzyme NQO1. These interesting results warrant further fractionation 
and isolation of the chemical constituents of this plant extract using bioassay-guided isolation 
schemes, which is underway. 
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Table 1.NQO1 Inducer Potency* of 22 Plant extracts for 11 plants.
 
*Potency is expressed as the concentration of test sample needed to double the NQO1 specific 
enzyme activity. N.R.=not reached up to extract concentration of 50 µg/ml. 
 
 
 
 
 
 
 
 
 
 
 
Extract CD (µg/ml)
AF 1:1 12.6
AF 70 13.0
AJ 1:1 16.0
AJ 70 N.R.
BU 1:1 22.0
BU 70 N.R.
ES 1:1 N.R.
ES 70 31.0
PA 1:1 N.R.
PA 70 N.R.
PI 1:1 3.2
PI 70 N.R.
PU 1:1 5.9
PU 70 N.R.
SA 1:1 50.0
SA 70 N.R.
SH 1:1 6.0
SH 70 5.9
TP 1:1 28.0
TP70 N.R.
TS 1:1 10.0
TS 70 9.0
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Fig.1 Images of assayed Egyptian plants in their original habitat: Achillea fragrantissima (1, AF), Artemisia 
judica (2, AJ), Ballota undulata (3, BU), Euphorbia santa-catherine (4, ES), Phlomis aurea (5, PA), 
Pulicaria incisa (6, PI), Stachys aegyptiaca (7, SA), Pulicaria undulata (8, PU), Seriphidium herba-alba (9, 
SH), Teucrium polium (10, TP) and Tanacetum sinaicum (11, TS). 
 
Accepted  form  @ JONM 
15 
 
 
Fig. 2. Dose response of NQO1 inducer activity of 22 extracts from 11 plant species.  
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Fig.3. Stabilization of NRF2 and upregulation of its related cytoprotective proteins by the PI 1:1 plant extract in Hepa1c1c7 cells.  
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Supporting information:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S1. Typical chromatograms of active plant extract, Pulicaria incisa (CH
2
Cl
2
: MeOH (1:1)).The separation conditions 
as follow: chromatogram column, ODS column (4.6×200 mm, 5μm); column temperature, 30°C; injection volume, 10μL; 
elution was performed at a flow rate of 1 ml/min, using as mobile phase a mixture of water (A) and methanol (B). The 
samples were eluted by the following gradient: 95% A and 5% B as initial conditions, 70% A and 30% B for 25 min, 
65% A and 35% B for 25 min, 30% A and 70% B for 15 min, 0% A and 100% B for 5 min and, finally, 95% A and 5% B 
for 5 min. Detection was performed at 220 and 254 nm. 
